1039 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex
Condition: SMALL CELL LUNG CARCINOMA
Intervention: Drug: Afatinib
9 Not yet recruiting Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin
Condition: Small Cell Lung Cancer
Interventions: Drug: apatinib;etoposide and cisplatin;   Drug: placebo;etoposide and cisplatin
10 Not yet recruiting A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Adenocarcinoma
Intervention: Drug: VAL401
11 Not yet recruiting An Intensive QT/QTc Study to Investigate the Effects of Rovalpituzumab Tesirine on Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Intervention: Drug: Rovalpituzumab Tesirine
12 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
13 Not yet recruiting Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: pembrolizumab 2 mg/kg;   Drug: Docetaxel 75 mg/m^2
14 Not yet recruiting A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Carboplatin
15 Not yet recruiting A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
Conditions: Advanced Cancer;   Metastatic Cancer;   Colorectal Cancer;   Non-small Cell Lung Cancer
Interventions: Drug: prexasertib;   Drug: ralimetinib
16 Not yet recruiting EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: EGFR-TKI;   Drug: Chemotherapy(pemetrexed/gemcitabine);   Drug: Chemotherapy(carboplatin)
17 Not yet recruiting Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Conditions: Metastatic Malignant Neoplasm in the Brain;   Metastatic Melanoma;   Mucosal Melanoma;   Ocular Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Radiation: Stereotactic Radiosurgery
18 Not yet recruiting A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Conditions: Advanced Cancer;   Metastatic Melanoma;   Metastatic Non-small Cell Lung Cancer;   Metastatic Pancreatic Ductal Adenocarcinoma;   Colorectal Cancer
Interventions: Drug: LY3214996;   Drug: Midazolam;   Drug: Abemaciclib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
19 Not yet recruiting Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
Condition: Lung Neoplasms
Intervention:
20 Not yet recruiting A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
Condition: Advanced or Metastatic Non-small Cell Lung Cancer
Interventions: Drug: TAS-114;   Drug: S-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years